secwatch.observer — SEC 8-K summary
======================================

Issuer:     Augmedix, Inc. (—)
CIK:        0001769804
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0001628280-24-022885
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Augmedix Q1 revenue up 40% to $13.5M; guides FY24 lower on AI purchasing slowdown
--------------------------------------------------------------------------------

- Revenue $13.5M (+40% YoY); gross margin 47.1% (up 150 bps).
- Net loss $6.5M vs $5.2M; adjusted EBITDA loss $5.1M vs $4.3M.
- Dollar-based Net Revenue Retention 143% vs 136% for Health Enterprise.
- CEO cites slower purchasing commitments; full-year revenue outlook lowered.
- Cash $37.3M; HCA Healthcare planning expansion of Augmedix Go to more EDs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1769804/000162828024022885/0001628280-24-022885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1769804/000162828024022885/augx-20240513.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-022885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer